HIGHLIGHTS
- who: Fred C. Semitala from the Department of Medicine, School of Medicine, Makerere University College have published the research: Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives, in the Journal: (JOURNAL)
- what: The aim of this qualitative study was to identify potential barriers to, and facilitators of, 3HP acceptance and completion, from the perspective of PLHIV in HIV/ AIDS care and health workers at a large, urban HIV/ AIDS clinic in Kampala, Uganda, and map these onto the COM . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.